{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:42Z","timestamp":1790985222848,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA277267"],"award-info":[{"award-number":["R21CA277267"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite substantial advances in early detection and therapeutic strategies, breast cancer remains a major cause of cancer-related morbidity and mortality worldwide. Changes in cytoskeletal proteins that typically regulate cellular architecture underpin tumor progression. Merlin, encoded by the\n                    <jats:italic>NF2<\/jats:italic>\n                    gene and a member of the ezrin\u2013radixin\u2013moesin protein family, functions as a critical cytoskeletal linker protein and a tumor suppressor that governs multiple oncogenic pathways and restricts epithelial\u2013mesenchymal plasticity. While Merlin deficiency alters cellular architecture, the precise impact of a Merlin-deficient breast tumor on remodeling its immune microenvironment remains largely undefined. In this study, we demonstrate that in breast cancer, Merlin deficiency displays attributes consistent with enhanced epithelial\u2013mesenchymal plasticity and enrichment of Hedgehog signaling. In vivo, Merlin-deficient tumors displayed accelerated growth and an immunosuppressive milieu characterized by increased abundance of regulatory T cells and M2-like macrophages. Treatment with Vismodegib, a pharmacological Hedgehog pathway inhibitor, reduced tumor growth of Merlin-deficient basal-like tumors, accompanied by a decrease in tumor-infiltrating regulatory T cells and immunosuppressive M2-like macrophages, and increased recruitment of pro-inflammatory M1-like macrophages. The data present Hedgehog inhibition as a targetable vulnerability of Merlin-deficient basal-like, triple-negative breast cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03223-7","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:13:11Z","timestamp":1783609991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Merlin deficiency supports an immunosuppressive milieu in breast cancer"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-4616","authenticated-orcid":false,"given":"Mohamed H.","family":"Elbahoty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Metge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr R.","family":"Elhamamsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5691-0765","authenticated-orcid":false,"given":"Melanie","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-1476","authenticated-orcid":false,"given":"Lalita A.","family":"Shevde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"3223_CR1","volume":"16","author":"A Rai","year":"2024","unstructured":"Rai A, Deshpande SG, Vaidya A, Shinde RK. Advancements in immunotherapy for breast cancer: mechanisms, efficacy, and future directions. Cureus. 2024;16:e68351.","journal-title":"Cureus"},{"key":"3223_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1321654","volume":"14","author":"F Carlino","year":"2024","unstructured":"Carlino F, Solinas C, Orditura M, Bisceglia MD, Pellegrino B, Diana A. Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications. Front Oncol. 2024;14:1321654.","journal-title":"Front Oncol"},{"key":"3223_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","volume":"87","author":"M Castaneda","year":"2022","unstructured":"Castaneda M, den Hollander P, Kuburich NA, Rosen JM, Mani SA. Mechanisms of cancer metastasis. Semin Cancer Biol. 2022;87:17\u201331.","journal-title":"Semin Cancer Biol"},{"key":"3223_CR4","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/cells12121620","volume":"12","author":"RGM Buenaventura","year":"2023","unstructured":"Buenaventura RGM, Merlino G, Yu Y. Ez-Metastasizing: the crucial roles of Ezrin in metastasis. Cells. 2023;12:1620.","journal-title":"Cells"},{"key":"3223_CR5","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400019RR","volume":"38","author":"R Vlashi","year":"2024","unstructured":"Vlashi R, Sun F, Zheng C, Zhang X, Liu J, Chen G. The molecular biology of NF2\/Merlin on tumorigenesis and development. FASEB J. 2024;38:e23809.","journal-title":"FASEB J"},{"key":"3223_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00544-7","volume":"18","author":"M Mota","year":"2020","unstructured":"Mota M, Shevde LA. Merlin regulates signaling events at the nexus of development and cancer. Cell Commun Signal. 2020;18:63.","journal-title":"Cell Commun Signal"},{"key":"3223_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep40773","volume":"7","author":"S Das","year":"2017","unstructured":"Das S, Jackson WP, Prasain JK, Hanna A, Bailey SK, Tucker JA, et al. Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling. Sci Rep. 2017;7:40773.","journal-title":"Sci Rep"},{"key":"3223_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9457","volume":"6","author":"Z-L Luo","year":"2015","unstructured":"Luo Z-L, Cheng S-Q, Shi J, Zhang H-L, Zhang C-Z, Chen H-Y, et al. A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma. Nat Commun. 2015;6:8457.","journal-title":"Nat Commun"},{"key":"3223_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/1878-0261.12896","volume":"15","author":"M Mota","year":"2021","unstructured":"Mota M, Metge BJ, Hinshaw DC, Alsheikh HA, Chen D, Samant RS, et al. Merlin deficiency alters the redox management program in breast cancer. Mol Oncol. 2021;15:942\u201356.","journal-title":"Mol Oncol"},{"key":"3223_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343:84\u20137.","journal-title":"Science"},{"key":"3223_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18632\/oncotarget.7494","volume":"7","author":"AK Morrow","year":"2016","unstructured":"Morrow AK, Das S, Meng E, Menezes ME, Bailey SK, Metge BJ, et al. Loss of tumor suppressor Merlin results in aberrant activation of Wnt\/\u03b2-catenin signaling in cancer. Oncotarget. 2016;7:14.","journal-title":"Oncotarget"},{"key":"3223_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","volume":"29","author":"G Pasello","year":"2018","unstructured":"Pasello G, Zago G, Lunardi F, Urso L, Kern I, Vlacic G, et al. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Ann Oncol. 2018;29:1258\u201365.","journal-title":"Ann Oncol"},{"key":"3223_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-018-2788-6","volume":"138","author":"S Wang","year":"2018","unstructured":"Wang S, Liechty B, Patel S, Weber JS, Hollmann TJ, Snuderl M, et al. Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors. J Neuro-Oncol. 2018;138:183\u201390.","journal-title":"J Neuro-Oncol"},{"key":"3223_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/cancers13071561","volume":"13","author":"H Yang","year":"2021","unstructured":"Yang H, Hall SRR, Sun B, Zhao L, Gao Y, Schmid RA, et al. NF2 and canonical Hippo-YAP Pathway define distinct tumor subsets characterized by different immune deficiency and treatment implications in human pleural mesothelioma. Cancers. 2021;13:1561.","journal-title":"Cancers"},{"key":"3223_CR15","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/s41388-019-0883-6","volume":"38","author":"Y Cui","year":"2019","unstructured":"Cui Y, Groth S, Troutman S, Carlstedt A, Sperka T, Riecken LB, et al. The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling. Oncogene. 2019;38:6370\u201381.","journal-title":"Oncogene"},{"key":"3223_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02940-8","volume":"23","author":"MA Ghalavand","year":"2023","unstructured":"Ghalavand MA, Asghari A, Farhadi M, Taghizadeh-Hesary F, Garshasbi M, Falah M. The genetic landscape and possible therapeutics of neurofibromatosis type 2. Cancer Cell Int. 2023;23:99.","journal-title":"Cancer Cell Int"},{"key":"3223_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/neuonc\/noae282","volume":"27","author":"Y-H Chung","year":"2024","unstructured":"Chung Y-H, Park S, Lee M, Lee J, Ji Y, Song YJ, et al. Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor. Neuro-Oncol. 2024;27:1241\u201355.","journal-title":"Neuro-Oncol"},{"key":"3223_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12195-021-00694-9","volume":"15","author":"B Buyuk","year":"2022","unstructured":"Buyuk B, Jin S, Ye K. Epithelial-to-mesenchymal transition signaling pathways responsible for breast cancer metastasis. Cell Mol Bioeng. 2022;15:1\u201313.","journal-title":"Cell Mol Bioeng"},{"key":"3223_CR19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1177\/1535370219881360","volume":"244","author":"S Jusino","year":"2019","unstructured":"Jusino S, Saavedra HI. Role of E2Fs and mitotic regulators controlled by E2Fs in the epithelial to mesenchymal transition. Exp Biol Med. 2019;244:1419\u201329.","journal-title":"Exp Biol Med"},{"key":"3223_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.24272\/j.issn.2095-8137.2020.095","volume":"41","author":"L Zeng","year":"2020","unstructured":"Zeng L, Li W, Chen CS. Breast cancer animal models and applications. Zool Res. 2020;41:477\u201394.","journal-title":"Zool Res"},{"key":"3223_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41556-018-0140-1","volume":"20","author":"H Dev","year":"2018","unstructured":"Dev H, Chiang TW, Lescale C, de Krijger I, Martin AG, Pilger D, et al. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. Nat Cell Biol. 2018;20:954\u201365.","journal-title":"Nat Cell Biol"},{"key":"3223_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41416-018-0216-5","volume":"119","author":"S-H Lee","year":"2018","unstructured":"Lee S-H, McIntyre D, Honess D, Hulikova A, Pacheco-Torres J, Cerd\u00e1n S, et al. Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo. Br J Cancer. 2018;119:622\u201330.","journal-title":"Br J Cancer"},{"key":"3223_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biomedicines11123136","volume":"11","author":"X Zhuang","year":"2023","unstructured":"Zhuang X, Martin TA, Ruge F, Zeng JJ, Li XA, Khan E, et al. Expression of Claudin-9 (CLDN9) in breast cancer, the clinical significance in connection with its subcoat anchorage proteins ZO-1 and ZO-3 and impact on drug resistance. Biomedicines. 2023;11:12.","journal-title":"Biomedicines"},{"key":"3223_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jnci\/djab222","volume":"114","author":"ES Villodre","year":"2022","unstructured":"Villodre ES, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, et al. NDRG1 in aggressive breast cancer progression and brain metastasis. J Natl Cancer Inst. 2022;114:579\u201391.","journal-title":"J Natl Cancer Inst"},{"key":"3223_CR25","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.2147\/OTT.S256654","volume":"13","author":"J Wang","year":"2020","unstructured":"Wang J, Pan W. The biological role of the collagen alpha-3 (VI) chain and its cleaved C5 domain fragment endotrophin in cancer. Onco Targets Ther. 2020;13:5779\u201393.","journal-title":"Onco Targets Ther"},{"key":"3223_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01618-3","volume":"25","author":"CA Hathaway","year":"2023","unstructured":"Hathaway CA, Rice MS, Collins LC, Chen D, Frank DA, Walker S, et al. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers. Breast Cancer Res. 2023;25:24.","journal-title":"Breast Cancer Res"},{"key":"3223_CR27","doi-asserted-by":"publisher","first-page":"84996","DOI":"10.18632\/oncotarget.18662","volume":"8","author":"H Wu","year":"2017","unstructured":"Wu H, Wang H, Guan S, Zhang J, Chen Q, Wang X, et al. Cell-specific regulation of proliferation by Ano1\/TMEM16A in breast cancer with different ER, PR, and HER2 status. Oncotarget. 2017;8:84996\u20135013.","journal-title":"Oncotarget"},{"key":"3223_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/life12101517","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gong W, Preis S, Dorn J, Kiechle M, Reuning U, et al. A pair of prognostic biomarkers in triple-negative breast cancer: KLK10 and KLK11 mRNA expression. Life. 2022;12:10.","journal-title":"Life"},{"key":"3223_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1242426","volume":"10","author":"Q Han","year":"2023","unstructured":"Han Q, Qiu S, Hu H, Li W, Li X. Role of Caveolae family-related proteins in the development of breast cancer. Front Mol Biosci. 2023;10:1242426.","journal-title":"Front Mol Biosci"},{"key":"3223_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04963-9","volume":"22","author":"D Lee","year":"2024","unstructured":"Lee D, Ham I-H, Oh HJ, Lee DM, Yoon JH, Son S-Y, et al. Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin \u03b21. J Transl Med. 2024;22:154.","journal-title":"J Transl Med"},{"key":"3223_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","volume":"35","author":"M Shen","year":"2019","unstructured":"Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, et al. Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting integrin\/FAK and EGFR signaling. Cancer Cell. 2019;35:64\u201380.e7.","journal-title":"Cancer Cell"},{"key":"3223_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol. 2023;20:714\u201338.","journal-title":"Cell Mol Immunol"},{"key":"3223_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms241814026","volume":"24","author":"B Stojanovic","year":"2023","unstructured":"Stojanovic B, Gajovic N, Jurisevic M, Stojanovic MD, Jovanovic M, Jovanovic I, et al. Decoding the IL-33\/ST2 Axis: its impact on the immune landscape of breast cancer. Int J Mol Sci. 2023;24:18.","journal-title":"Int J Mol Sci"},{"key":"3223_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41417-025-00897-6","volume":"32","author":"M Tokumasu","year":"2025","unstructured":"Tokumasu M, Sato A, Ito-Kureha T, Yamamoto M, Ohmine N, Semba K, et al. Tob negatively regulates NF-\u03baB activation in breast cancer through its association with the TNF receptor complex. Cancer Gene Ther. 2025;32:573\u201383.","journal-title":"Cancer Gene Ther"},{"key":"3223_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.91","volume":"7","author":"AE Hall","year":"2016","unstructured":"Hall AE, Lu WT, Godfrey JD, Antonov AV, Paicu C, Moxon S, et al. The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration. Cell Death Dis. 2016;7:e2184.","journal-title":"Cell Death Dis"},{"key":"3223_CR36","first-page":"587","volume":"7","author":"WK Darkwah","year":"2018","unstructured":"Darkwah WK, Aidoo G, Ao Y, Owusu Danquah K, Adjei E, Adankwah E, et al. Assessment of proliferative index in different grades of breast cancers using AgNOR (Agyrophilic Nuclear Organizer Region) expression. Beni-Suef Univ J Basic Appl Sci. 2018;7:587\u201392.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"3223_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/26895293.2021.1925356","volume":"14","author":"WK Darkwah","year":"2021","unstructured":"Darkwah WK, Aidoo G, Akoto D, Alhassan K, Adormaa BB, Puplampu JB. Proliferative activity of various grades and types of breast carcinoma using AgNOR (Argyrophilic Nuclear Organizer Region) expression and its prognostic significance. All Life. 2021;14:375\u201391.","journal-title":"All Life"},{"key":"3223_CR38","unstructured":"Priyanka DK, Praveen Kumar KG. The prognostic value of AgNOR parameter in various grades of breast carcinomas. Int J Acad Med Pharm. 2025;7:770\u20134."},{"key":"3223_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153478","volume":"223","author":"A Garc\u00eda-Mart\u00ednez","year":"2021","unstructured":"Garc\u00eda-Mart\u00ednez A, P\u00e9rez-Balaguer A, Ortiz-Mart\u00ednez F, Pomares-Navarro E, Sanmart\u00edn E, Garc\u00eda-Escolano M, et al. Hedgehog gene expression patterns among intrinsic subtypes of breast cancer: prognostic relevance. Pathol Res Pract. 2021;223:153478.","journal-title":"Pathol Res Pract"},{"key":"3223_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2235-0","volume":"5","author":"NG Bediaga","year":"2016","unstructured":"Bediaga NG, Beristain E, Calvo B, Viguri MA, Gutierrez-Corres B, Rezola R, et al. Luminal B breast cancer subtype displays a dicotomic epigenetic pattern. SpringerPlus. 2016;5:623.","journal-title":"SpringerPlus"},{"key":"3223_CR41","doi-asserted-by":"publisher","first-page":"e10606","DOI":"10.1002\/btm2.10606","volume":"9","author":"SM Orbach","year":"2024","unstructured":"Orbach SM, DeVaull CY, Bealer EJ, Ross BC, Jeruss JS, Shea LD. An engineered niche delineates metastatic potential of breast cancer. Bioeng Transl Med. 2024;9:e10606.","journal-title":"Bioeng Transl Med"},{"key":"3223_CR42","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/2326-6066.CIR-22-0426","volume":"11","author":"DC Hinshaw","year":"2023","unstructured":"Hinshaw DC, Benavides GA, Metge BJ, Swain CA, Kammerud SC, Alsheikh HA, et al. Hedgehog signaling regulates Treg to Th17 conversion through metabolic rewiring in breast cancer. Cancer Immunol Res. 2023;11:687\u2013702.","journal-title":"Cancer Immunol Res"},{"key":"3223_CR43","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1158\/0008-5472.CAN-20-1723","volume":"81","author":"DC Hinshaw","year":"2021","unstructured":"Hinshaw DC, Hanna A, Lama-Sherpa T, Metge B, Kammerud SC, Benavides GA, et al. Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages. Cancer Res. 2021;81:5425\u201337.","journal-title":"Cancer Res"},{"key":"3223_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fern\u00e1ndez-Valle C. Role of Merlin\/NF2 inactivation in tumor biology. Oncogene. 2016;35:537\u201348.","journal-title":"Oncogene"},{"key":"3223_CR45","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.21037\/tcr-23-1179","volume":"13","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu J. NF2 is a candidate diagnosis, prognostic, and immunotherapeutic biomarker: a systematic pan-cancer analysis. Transl Cancer Res. 2024;13:1026\u201342.","journal-title":"Transl Cancer Res"},{"key":"3223_CR46","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1101\/gad.1938710","volume":"24","author":"S Benhamouche","year":"2010","unstructured":"Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, et al. Nf2\/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev. 2010;24:1718\u201330.","journal-title":"Genes Dev"},{"key":"3223_CR47","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/onc.2014.185","volume":"34","author":"PA Guerrero","year":"2015","unstructured":"Guerrero PA, Yin W, Camacho L, Marchetti D. Oncogenic role of Merlin\/NF2 in glioblastoma. Oncogene. 2015;34:2621\u201330.","journal-title":"Oncogene"},{"key":"3223_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat. Genet.2022;54:649\u201359.","journal-title":"Nat. Genet."},{"key":"3223_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.","journal-title":"J Hematol Oncol"},{"key":"3223_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5732\/cjc.011.10226","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer. 2011;30:603\u201311.","journal-title":"Chin J Cancer"},{"key":"3223_CR51","doi-asserted-by":"crossref","unstructured":"Nouri SH, Nitturi V, Ledbetter E, English CW, Lau S, Klisch TJ, et al. Role of NF2 mutation in the development of eleven different cancers. Cancers. 2024;17:64.","DOI":"10.3390\/cancers17010064"},{"key":"3223_CR52","volume":"2","author":"CJ Hannan","year":"2020","unstructured":"Hannan CJ, Lewis D, O\u2019Leary C, Donofrio CA, Evans DG, Roncaroli F, et al. The inflammatory microenvironment in vestibular schwannoma. Neurooncol Adv. 2020;2:vdaa023.","journal-title":"Neurooncol Adv"},{"key":"3223_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers13225664","volume":"13","author":"F Cersosimo","year":"2021","unstructured":"Cersosimo F, Barbarino M, Lonardi S, Vermi W, Giordano A, Bellan C, et al. Mesothelioma malignancy and the microenvironment: molecular mechanisms. Cancers. 2021;13:22.","journal-title":"Cancers"},{"key":"3223_CR54","doi-asserted-by":"publisher","first-page":"1548241","DOI":"10.1080\/2162402X.2018.1548241","volume":"8","author":"A Hanna","year":"2019","unstructured":"Hanna A, Metge BJ, Bailey SK, Chen D, Chandrashekar DS, Varambally S, et al. Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer. Oncoimmunology. 2019;8:1548241.","journal-title":"Oncoimmunology"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03223-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:37Z","timestamp":1790982157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03223-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3223"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03223-7","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"During the preparation of this work, the authors used GPT-4 to improve the readability of the manuscript. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Statement","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"397"}}